Add videos to your saved list and come back to them any time.

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both ...

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both companies ...

Spanish renewables company X-Elio has signed a 10-year Power Purchase Agreement (PPA) to supply 245GWh of clean energy annually to a cohort of four pharmaceutical companies. The cohort, which includes ...